Citicoline tablets 200 mg/ 500 mg/ 750 mg/ 1000 mg

Citicoline tablets 200 mg/ 500 mg/ 750 mg/ 1000 mg
Product Description

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline tablets 200 mg/ 500 mg/ 750 mg/ 1000 mg. It belongs to central nervous system finish formulations products category. Contact us for more information.

Read more Show less

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Approvals/Standards
  • Supplied from
    India
More specifications Fewer specifications

BDR PHARMACEUTICALS INTERNATIONAL PVT.

  • IN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Pharmaceutical company
View company profile

More Products from BDR PHARMACEUTICALS INTERNATIONAL PVT. (99)

  • Choline alfoscerate 400 mg soft caps & 250 mg/ml injection

    Product Choline alfoscerate 400 mg soft caps & 250 mg/ml injection

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes choline alfoscerate 400 mg soft caps & 250 mg/ml injection. It belongs to central nervous system finish formulations products category. Contact us for more information.
  • Cisplatin injection 10 mg/ 50 mg

    Product Cisplatin injection 10 mg/ 50 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes cisplatin injection 10 mg/ 50 mg. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.
  • Citalopram hydrobromide

    Product Citalopram hydrobromide

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citalopram hydrobromide. It belongs to antideperessant apis category. Contact us for more information.
  • Citicoline 500 mg + peracetam 400/800 mg

    Product Citicoline 500 mg + peracetam 400/800 mg

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline 500 mg + peracetam 400/800 mg. It belongs to central nervous system finish formulations products category. Contact us for more information.
  • Citicoline injection 250 mg/ml

    Product Citicoline injection 250 mg/ml

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline injection 250 mg/ml. It belongs to central nervous system finish formulations products category. Contact us for more information.
  • Citicoline sodium

    Product Citicoline sodium

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes citicoline sodium. It belongs to antialzheimer apis category. Contact us for more information.
  • [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]

    Product [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [(2,6- dimethylphenyl) aminocarbonylmethyl]-chloride [1311-01-7]. It belongs to ranolazine intermediates products category. Contact us for more information.
  • [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]

    Product [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [1-hydroxy-2-(3-pyridinyl) ethylidene]-biphosphonic acid [105462-24-6]. It belongs to risedronate sodium intermediates products category. Contact us for more information.
  • [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]

    Product [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [1,1'-biphenyl]-2-carbonitrile-4-[(2-butyl-4-oxo-1,3-diazaspiro [4.4]-non- 1-en-3-yl)- methyl]. It belongs to irbesartan intermediates products category. Contact us for more informat...
  • [138401-24-8]

    Product [138401-24-8]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes [138401-24-8]. It belongs to irbesartan intermediates products category. Contact us for more information.
  • 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]

    Product 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 1- (2-methoxyphenoxy) -2,3-epoxypropane. [2210-74-4]. It belongs to ranolazine intermediates products category. Contact us for more information.
  • 1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]

    Product 1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]

    Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes 1-[(2,6- dimethylphenyl) aminocarbonylmethyl piperazine [5294-61-1]. It belongs to ranolazine intermediates products category. Contact us for more information.
show all 99 other products

BDR PHARMACEUTICALS INTERNATIONAL PVT. resources (1)